Picture of ExpreS2ion Biotech Holding AB logo

EXPRS2 — ExpreS2ion Biotech Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: ExpreS2ion's JV AdaptVac Receives Danish Innobooster Grant Of SEK 1.2 Mln

Oct 17 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION'S JOINT VENTURE ADAPTVAC RECEIVES DANISH
INNOBOOSTER
GRANT OF 1.2 MSEK FOR FOR BREAST CANCER STUDIES IN DOGS
    * GRANT PROVIDES FURTHER RESOURCES FOR DEVELOPMENT OF A SAFE
AND
EFFECTIVE TREATMENT FOR DOGS DIAGNOSED WITH DER2+ CANCER
    * AIM OF PROJECT IS TO DEVELOP VETERINARY CANCER PRODUCTS,
SPECIFICALLY FOR CANINE HOMOLOGUE OF HUMAN HER2 CANCER TARGET.
    * PROGRAM WILL GENERATE VALUABLE SUPPORTIVE DATA FOR
COMPANY'S
HUMAN HER2+ BREAST CANCER PROGRAM AV001.

Source text for Eikon:  ID:nWkr42q3dT 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on ExpreS2ion Biotech Holding AB

See all news